How it Works

We have deployed our web tool to help laboratories analyze the COVID-19 RT-PCR tests. Due to lockdown in many countries, the virus is mutating differently in various parts of the world. Because of this, some tests may be effective in one country and irrelevant in another. That is exactly why we developed our tool to help laboratories verify their potential tests against the analysis of our virus’s genome database.

Enter the test primers using our clean interface

Specify the exact primers of RT-PCR test, as well as other parameters, such as hybridization temperature.

Contact Us

Estimate amplification chance and determine virus mutatations

On the table one can see the amplification chance (from 0 to 1), as well as specific mutations, which can influence the outcome of PCR test.

Contact Us

Perform large dataset geoanalysis

Because of independent mutations and lockdowns, SARS-CoV-2 is appearing in different mutations in various regions. This visualization can help to determine what the test effectiveness is based on location

Contact Us

Estimate mutation robustness

Our machine learning models calculate the probabilities of future mutations in specific regions in genome. Based on that, we are able to show the sensitivity of PCR test in the following months, which can be seen on the graphs here.

Contact Us

Our solutions were recognized in multiple contests

We won the 1st prize in “Applications of Tomorrow”, competition organised by Polish Development Fund and were called the most promising healthcare startup in the wake of the COVID-19 pandemic.

We are the winners of EuvsVirus hackathon - we were recognized by the European Commission as one of the 117 projects in Europe that can change the course of the COVID-19 outbreak.

We have won 2nd prize during a prestigious Researchathon organised by Stanford University.

Our work started during hackathon Hack the Crisis: Tech for Good, where we managed to win the main prize.

Who are we and what is our identity?

We are a team of young professionals and aspiring entrepreneurs, which share the passion for our project. Our experience from companies such as BCG, PwC, PAN, Bytedance helps us build a better tomorrow.

Our mission is to:


  • Understand the behavior of the virus
  • Get insights in the evolution of the epidemic
  • Predict future virus mutations
  • Work with laboratories and pharmaceutical companies to help fight the epidemic and save lives

Piotr Grzegorczyk

Chief Executive Officer Chief Business Officer

(CEO & CBO)

Grzegorz Preibisch

Chief Executive Officer Chief Scientific Officer

(CEO & CSO)

Piotr Styczyński

Chief Engineering Officer

(CEngO)

Stanisław Giziński

Chief Technology Officer

(CTO)

Kazimierz Anhalt

Chief Marketing Officer

(CMO)

Our scientific board

    Henryk Michalewski

    Professor at the University of Warsaw and a Visiting Professor at Google

      Krzysztof Pyrć

      Professor at Jagiellonian University, recognizable virusology and microbiology expert

        Jakub Gołąb

        Professor at the Medical University of Warsaw, innovator in the oncological treatment technology

          Paweł Gora

          PhD candidate in Computer Science at the University of Warsaw

            Anna Gambin

            Professor at the University of Warsaw.